Research
South African trial tests off-the-shelf killer cells against lymphoma
The Brief
- South African researchers are running a trial of off-the-shelf immune cells against lymphoma that has returned or resisted treatment
- The approach avoids manufacturing a separate treatment from each patient's own cells
Why it matters
It tests whether allogeneic, ready-made immune cell therapy can work for hard-to-treat lymphoma, which could make cell therapies cheaper and faster to deliver.
Who’s affected
- Lymphoma patients with relapsed or refractory disease
- Clinical researchers working on cell therapies
- #lymphoma
- #cell therapy
- #clinical trial
- #oncology
- #south africa
South African researchers are testing "off-the-shelf" immune cells against lymphoma that has returned or resisted treatment, investigating an approach that avoids having to manufacture a separate treatment from each patient's own cells.
Timeline
Medical Xpress reports on the South African trial
Medical Xpress - latest medical and health news stories
South African trial tests off-the-shelf killer cells against lymphoma